SAN

91.43

-1.73%↓

MRK1

114.35

+0.26%↑

SHL.DE

46.25

-3.87%↓

ARGX

508.2

-0.86%↓

FRE

42.98

-0.78%↓

SAN

91.43

-1.73%↓

MRK1

114.35

+0.26%↑

SHL.DE

46.25

-3.87%↓

ARGX

508.2

-0.86%↓

FRE

42.98

-0.78%↓

SAN

91.43

-1.73%↓

MRK1

114.35

+0.26%↑

SHL.DE

46.25

-3.87%↓

ARGX

508.2

-0.86%↓

FRE

42.98

-0.78%↓

SAN

91.43

-1.73%↓

MRK1

114.35

+0.26%↑

SHL.DE

46.25

-3.87%↓

ARGX

508.2

-0.86%↓

FRE

42.98

-0.78%↓

SAN

91.43

-1.73%↓

MRK1

114.35

+0.26%↑

SHL.DE

46.25

-3.87%↓

ARGX

508.2

-0.86%↓

FRE

42.98

-0.78%↓

Search

Pharming Group NV

Open

0.921 -0.86

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.91

Max

0.985

Schlüsselkennzahlen

By Trading Economics

Einkommen

-18M

-15M

Verkäufe

-14M

79M

EPS

-0.02

Gewinnspanne

-18.61

Angestellte

404

EBITDA

1.9M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+110.73% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-14M

595M

Vorheriger Eröffnungskurs

1.78

Vorheriger Schlusskurs

0.921

Pharming Group NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Mai 2025, 23:48 UTC

Heiße Aktien

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22. Mai 2025, 23:07 UTC

Top News

Fortescue Energy CEO to Resign in Executive Overhaul

22. Mai 2025, 23:03 UTC

Wichtige Markttreiber

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22. Mai 2025, 23:59 UTC

Market Talk

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22. Mai 2025, 23:45 UTC

Market Talk

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22. Mai 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

22. Mai 2025, 23:23 UTC

Market Talk

Global Energy Roundup: Market Talk

22. Mai 2025, 23:23 UTC

Market Talk

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22. Mai 2025, 23:12 UTC

Top News

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22. Mai 2025, 21:54 UTC

Top News

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22. Mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22. Mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Mai 2025, 20:46 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22. Mai 2025, 20:39 UTC

Ergebnisse

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22. Mai 2025, 20:36 UTC

Top News

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22. Mai 2025, 20:36 UTC

Top News
Ergebnisse

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22. Mai 2025, 20:32 UTC

Top News
Ergebnisse

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22. Mai 2025, 20:27 UTC

Top News

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22. Mai 2025, 20:20 UTC

Top News

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22. Mai 2025, 20:17 UTC

Top News

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22. Mai 2025, 20:16 UTC

Ergebnisse

Intchains Group 1Q Rev $18.2M >ICG

22. Mai 2025, 20:15 UTC

Top News

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22. Mai 2025, 20:08 UTC

Top News
Ergebnisse

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22. Mai 2025, 20:05 UTC

Top News

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22. Mai 2025, 20:04 UTC

Ergebnisse

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22. Mai 2025, 20:04 UTC

Ergebnisse

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Net $68M >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q EPS 25c >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Adj EPS $2.23 >WDAY

Peer-Vergleich

Kursveränderung

Pharming Group NV Prognose

Kursziel

By TipRanks

110.73% Vorteil

12-Monats-Prognose

Durchschnitt 2.002 EUR  110.73%

Hoch 2 EUR

Tief 2 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pharming Group NV – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.